Bechara et al., 2015*1717. Bechara CS, Lacerda Filho A, Ferrari MLA, Andrade DAR, Luz MMP, Silva RG. Montreal classification of patient operated for Crohn’s disease and identification of surgical recurrence predictors. Rev Col Bras Cir. 2015;42:97-104.
|
Brazil |
1992-2012 |
4.8% |
|
|
de Barros et al., 2017*1818. Barros KSC, Flores C, Harlacher L, Francesconi CFM. Evolution of Clinical Behavior in Crohn’s Disease: Factors Associated with Complicated Disease and Surgery. Dig Dis Sci. 2017;62:2481-8.
|
Brazil |
2005-2012 |
29.6% |
|
|
Arantes et al., 20172323. Arantes JAV, dos Santos CHM, Delfino BM, da Silva BA, de Souza RMM, de Souza TMM, et al. Epidemiological profile and clinical characteristics of patients with intestinal inflammatory disease. J Coloproctology. 2017;37:273-8.
|
Brazil |
2008-2016 |
20.2% (IFX) |
5.4% (IFX) |
|
|
|
|
33.6% (ADA) |
5.4% (ADA) |
|
da Silva et al., 2015#2121. Silva BC, Lyra AC, Mendes CMC, Ribeiro CPO, Lisboa SRO, de Souza MTL, et al. The Demographic and Clinical Characteristics of Ulcerative Colitis in a Northeast Brazilian Population. Biomed Res Int. 2015;2015:1-8.
|
Brazil |
2011-2012 |
|
1.5% |
|
Lima-Martins et al., 20182424. Lima Martins A, Volpato RA, Zago-Gomes M da P. The prevalence and phenotype in Brazilian patients with inflammatory bowel disease. BMC Gastroenterol. 2018;18:87.
|
Brazil |
2013-2014 |
43.4% |
4.5% |
|
Vivan et al., 20172525. Vivan TK, Santos BM, dos Santos CHM. Quality of life of patients with inflammatory bowel disease. J Coloproctology. 2017;37:279-84.
|
Brazil |
2016-2017 |
|
|
37.93% |
Lima et al., 20172626. Lima CA, Lyra AC, Mendes CMC, Lopes MB, Coqueiro FG, Rocha R, et al. Bone mineral density and inflammatory bowel disease severity. Brazilian J Med Biol Res. 2017;50:1-8.
|
Brazil |
not reported |
18.3% |
|
|
Kleinubing-Junior et al., 20112727. K Kleinubing Júnior H, Pinho MDSL, Ferreira LC, Bachtold GA, Merki A. Outpatients profile with inflammatory bowel disease. Arq Bras Cir Dig. 2011;24:200-3.
|
Brazil |
not reported |
8.5% |
2% |
|
Simian et al., 20162828. Simian D, Fluxá D, Flores L, Lubascher J, Ibáñez P, Figueroa C, et al. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients. World J Gastroenterol. 2016;22:5267-75.
|
Chile |
2012-2015 |
34% |
7% |
|
Juliao-Baños et al., 20102929. Baños FJ, Vélez MHR, Arango JFF, Gómez JHD, Zuluaga JIM, Arango CM, et al. Phenotypes and natural history of Inflammatory Bowel Disease (IBD) in a referral population in Medellín, Colombia. Rev Colomb Gastroenterol. 2010;25:240-51.
|
Colombia |
2001-2009 |
46.9% |
7.4% |
13.4% |
Rodríguez-Castro et al., 2013*1919. Rodríguez-Castro KI, Gutiérrez-Ramírez C, Avendaño-Alvarado G. Descripción epidemiológica y tratamiento de los pacientes con enfermedad de Crohn. Acta Méd Costarric. 2013;55:182-7.
|
Costa Rica |
1990-2009 |
25% |
|
|
García et al., 2014*2020. Hano García OM, Andrade Gomes S, Villa Jiménez OM, González Fabián L, Wood Rodríguez L. Caracterización de pacientes con enfermedad de Crohn atendidos en el Instituto de Gastroenterología de Cuba - Characterization of patients with Crohn’s disease cared for at the Institute of Gastroenterology of Cuba. Rev Cuba Investig Biomédicas. 2014;33:253-67.
|
Cuba |
2011-2012 |
3.8% |
|
|
Yamamoto-Furusho et al., 20153030. Yamamoto-Furusho JK, Sarmiento-Aguilar A. Mild clinical behaviour of Crohn disease in elderly patients in a Latin American country: A case-control study. Can J Gastroenterol Hepatol. 2015;29:435-9.
|
Mexico |
1983-2013 |
1.51% |
|
|
Yamamoto-Furusho et al., 2009#3131. Yamamoto-Furusho JK. Clinical epidemiology of ulcerative colitis in Mexico: A single hospital-based study in a 20-year period (1987-2006). J Clin Gastroenterol. 2009;43:221-4.
|
Mexico |
1987-2006 |
|
0% |
|
de la Cruz-Guillen et al., 2011#2222. De La Cruz-Guillén AA, Cortés-Espinosa T, Sánchez-Chávez X, López Gómez JG, Quintero Aguilar G, Reyes Zermeño MG, et al. Comportamiento clínico de la colitis ulcerosa crónica inespecífica en pacientes del CMn 20 de Noviembre, ISSSte, y comparación con la bibliografía Americana. Med Interna Mex. 2011;27:224-30.
|
Mexico |
1990-2008 |
|
7.35% |
|
Sarmiento et al., 20183232. Yamamoto-Furusho J, Sarmiento A, Toledo-Mauriño J, Bozada-Gutiérrez K, Bosques-Padilla, Martínez-Vázquez FM, et al. Clinical and sociodemographical characteristics of inflammatory bowel disease in Mexico : Multicentric nation - wide study ( EPIMEX - IBD ). Poster presentation P839. ECCO congress 2018.
|
Mexico |
not reported |
37.4% |
16.2% |
|
Paredes-Méndez et al., 20163333. Mendez JP, Moreno GO, Plata ALMR, Molina LL, Ordoñes KA, Gamio JLA, et al. Caracteristicas epidemiologicas y clinicas de la enfermedad inflamatoria intestinal en un hospital de referencia de Lima-Peru. Rev Gastroenterol Peru. 2016;36:209-18.
|
Peru |
2004-2014 |
33.3% |
2.4% |
|
Melendez et al., 20113434. Melendez J, Larregui Y, Vazquez J, Carlo V, Torres E. Medication profiles Puerto Rico IBD. P R Health Sci J. 2011;30:3-8.
|
Puerto Rico |
1995-2007 |
9.7% |
0.8% |
|
Luciano et al., 20183535. Luciano MJ, Noria A, Iade B. P688 Demographic, clinical, and therapeutic characteristics of a cohort of 238 patients with ulcerative colitis from two medical centres from Uruguay. J Crohn’s Colitis. 2018;12(Suppl1):S458-9.
|
Uruguay |
1954-2017 |
|
1.4% |
|